CBL2 Tuesday Group 34

Pseudohalide combination therapy for class 3 CFTR mutation to improve quality of life. By Colman Leung, Lara Abu-Zarour, Linzhi Wu, Rohan Tailor, Sarah Watkins and Tara Bellaiche. References Akabas, MH 2000, ‘Cystic Fibrosis Transmembrane Discover A Lot More

Read More →